MoneyWorks4Me

USFDA inspects Neuland Laboratories’ manufacturing facility in Telangana

17 Aug 2026 Evaluate

The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 3 manufacturing facility, located at Gaddapotharam village, Jinnaram, Sangareddy District, Telangana from August 10, 2026 to August 14, 2026.

At the conclusion of the inspection, the USFDA issued a Form 483 with one observation. The observation pertains to procedural improvements in water and environmental monitoring to include new organisms beyond those listed in the United States Pharmacopeia (USP). 

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.


Neuland Laboratories Share Price

23294.80 -267.45 (-1.14%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: